| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC3514 |
| Trial ID | NCT05949125 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Allo-RevCAR01-T |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Multicenter, Open-label, Phase 1 Study of Allo-RevCAR01-T-CD123 Consisting of Genetically Modified T Cells Carrying Reverse Chimeric Antigen Receptors (Allo RevCAR01 T) in Combination With CD123 Target Module (R-TM123) for the Treatment of Patients With Selected Hematologic Malignancies Positive for CD123 |
| Year | 2024 |
| Country | Germany |
| Company sponsor | AvenCell Europe GmbH |
| Other ID(s) | AVC-201-01|2022-501797-19-00 |
| Cohort 1 | |||||||||||
|
|||||||||||